The article, A Randomized Control Trial of Cefiderocol Versus Standard Therapy for Gram-Negative Bacterial Bloodstream Infections: Benefit and Risk Assessment Using DOOR and Generalized Pairwise Comparisons, was published in CID.
D
Daniel GriffinHOST
43:25
You ready for this? These are the results of the Game Changer trial.
S
Sarah DongHOST
43:29
It's pretty great.
We value your privacy
We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.